Mika Rämet, M.D., Ph.D., Professor of Paediatrics and Experimental Immunology, and the Chief Medical Officer ofFVR since 2022, is leaving his duties in the company as of 1st of February, 2024.

”We thank Mika warmly for his valuable contribution to the advancement of public health security through high quality, reliable vaccine research,” says Ilkka Haukijärvi, CEO of FVR.

The company will announce the future organization of the responsibilities in question at a later stage.

23rd of November, 2023

Ilkka Haukijärvi, CEO
FVR – Finnish Vaccine Research Ltd’s Board of Directors

Contact for inquiries:
Marikka Nevamäki
Chief Communications and Marketing Officer
tel. +358 40 417 9684